Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Times Interest Earned of -$0.35 for Q1 2026, up 81.34% year-over-year from -$0.19 in Q1 2025, and up 95.09% quarter-over-quarter from -$7.15 in Q4 2025.
Powered by 
Analysis
Maravai Lifesciences Holdings (MRVI) Times Interest Earned (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 81.34% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$4.48 (up 55.99% YoY), while the FY2025 annual figure was -$6.25, down 1738.05% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.35, up from -$7.15 in the prior quarter.
- The five-year high for Times Interest Earned was $12.44 in Q4 2022, with the low at -$7.15 in Q4 2025.
- The 5-year median for Times Interest Earned is -$0.59 (2023), against an average of $0.24.
- The sharpest annual moves came in 2024 and 2026: Times Interest Earned sank 1699.75% in 2024, then surged 81.34% in 2026.
- Maravai Lifesciences Holdings' Times Interest Earned stood at $12.44 in 2022, then slumped by 104.18% to -$0.52 in 2023, then plunged by 544.39% to -$3.35 in 2024, then tumbled by 113.65% to -$7.15 in 2025, then soared by 95.09% to -$0.35 in 2026.
- Business Quant data shows MRVI's Times Interest Earned at -$0.35 in Q1 2026, -$7.15 in Q4 2025, and -$1.56 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn | -3.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.14 |
| Mar 31, 2026 | -0.38 |
| Dec 31, 2025 | -8.97 |
| Sep 30, 2025 | -6.00 |
| Jun 30, 2025 | -9.73 |
| Mar 31, 2025 | -7.25 |
| Dec 31, 2024 | -3.35 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -1.74 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.65 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 10.73 |
| Sep 30, 2022 | 37.28 |
| Jun 30, 2022 | 40.75 |
| Mar 31, 2022 | 62.83 |
| Dec 31, 2021 | 22.01 |
| Sep 30, 2021 | 20.22 |